Nathan D. Jorgensen, Chief Financial Officer at Voyager Therapeutics, Inc. (VYGR), sold 7,666 shares at $4.78 ($37K) on 2025-10-03, disclosed to the SEC on 2025-10-07.
Open-market sale of $37k VYGR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.